Table 1.
Baseline demographic and clinical characteristics compared between the angiographic and intravascular imaging guidance groups.
| Characteristics | Angiographic guidance | Imaging guidance (IVUS+OCT) | p |
|---|---|---|---|
| (n = 77) | (n = 188) | ||
| Age (years) | 74.48 ± 0.1 | 72.81 ± 0.2 | 0.169 |
| Male sex | 34 (44.2%) | 104 (55.3%) | 0.099 |
| Diabetes mellitus | 51 (66.2%) | 109 (58.0%) | 0.212 |
| Hypertension | 70 (90.9%) | 180 (95.7%) | 0.145 |
| Dyslipidemia | 53 (68.8%) | 136 (72.3%) | 0.566 |
| Chronic kidney disease | 11(14.3%) | 39 (20.7%) | 0.222 |
| On renal replacement therapy | 5 (6.5%) | 11 (5.9%) | 0.784 |
| Previous PCI in target vessel | 4 (5.2%) | 16 (8.5%) | 0.354 |
| Previous CABG | 12 (15.6%) | 14 (7.4%) | 0.043 |
| Prior myocardial infarction | 18 (23.4%) | 49 (26.1%) | 0.648 |
| Smoker | 16 (20.8%) | 49 (26.1%) | 0.364 |
| Clinical syndrome | |||
| STEMI | 3 (3.9%) | 3 (1.6%) | |
| Non-ST-ASC | 26 (33.8%) | 76 (40.4%) | 0.333 |
| Stable CAD | 48 (62.3%) | 109 (58.0%) | |
| Antiplatelet (P2Y12) or anticoagulant | |||
| Clopidogrel | 66 (85.7%) | 159 (84.6%) | |
| Ticagrelor | 5 (6.5%) | 24 (12.8%) | 0.106 |
| Prasugrel | 3 (3.9%) | 2 (1.1%) | |
| Warfarin | 3 (3.9%) | 3 (1.6%) |
Data presented as frequency and percentage or mean ± standard deviation.
A p < 0.05 indicates statistical significance (Bold).
IVUS, intravascular ultrasound; OCT, optical coherence tomography; PCI, percutaneous coronary intervention; CABG, coronary bypass graft; STEMI, ST-segment elevation myocardial infarction; Non-ST-ASC, non-ST elevation acute coronary syndrome; CAD, coronary artery disease.